Session Details

Presentation numberED1-01

Moderator

Philippe Bedard, Princess Margaret Cancer Centre, Toronto, ON, Canada

Presentation numberED1-02

Actionable mutations in HR+/HER2- Disease

Maria Coakley, BC Cancer Vancouver, Vancouver, BC, Canada

Presentation numberED1-03

HER2-Low to HER2-Ultralow: Redefining HER2-Targeted Therapy

Shanu Modi, Memorial Sloan Kettering Cancer Center, New York, NY

Presentation numberED1-04

Immune Biomarkers Driving Immunotherapy Selection in Metastatic TNBC

Giampaolo Bianchini, IRCCS San Raffaele Hospital, MIlan, Italy

Presentation numberED1-05

Biomarkers for the WIN!

Kelly Shanahan, METAvivor Research and Support, South Lake Tahoe, CA